Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
ADHD News

New Guidelines For GP's Revolutionise Treatment For Hyperactivity Disorders

Main Category: ADHD
Also Included In: Psychology / Psychiatry
Article Date: 05 Feb 2007 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:3 and a half stars

3.31 (16 votes)

Health Professional:4 stars

3.6 (10 votes)

Article Opinions: 1 posts

New guidelines published this month (January 2007) in the Journal of Psychopharmacology will help to treat ADHD (Attention-Deficit/Hyperactivity Disorder), a condition that is traditionally associated with children but which is now increasing in adults. The guidelines will provide authoritative information to health professionals at a time when there is currently great uncertainty amongst GPs on how to treat the condition.

ADHD in the population is considered to be about four per cent making it a common disorder. There are no licensed drugs for managing ADHD specifically in adults, leading to uncertainty amongst health professionals on how best to treat these new cases. Yet drugs licensed for related conditions have proven to be effective.

The British Association of Psychopharmacology (BAP) guidelines provide the appropriate evidence and experience to permit health professionals to use unlicensed medicines if the clinical need cannot be met by licensed medicines, as advised by the British National Formulary (BNF).

"Treatment relieves suffering for the patient and family, and also alleviates social costs in unemployment, crime, incarceration, smoking, substance use and driving accidents", said Professor David Nutt from the BAP consensus group. "This information needs to be addressed by the NHS so that resources can be redirected to provide appropriate and evidence-based care for adults with ADHD."

The BAP guidelines on adult ADHD are based on expert opinion derived from childhood evidence. It is the first time that guidelines for ADHD in adults, and in adolescents in transition to adult services, have been published and arrive at a time when they can influence the new specialist services that the NHS is establishing in response to this growing need.

SAGE PUBLICATIONS
http://sagepub.co.uk/




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
INTUNIV (Guanfacine) Extended Release Tablets For ADHD In Children And Adolescents Approved By FDA
05 Sep 2009
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV™ (guanfacine) Extended Release...


ADHD Therapy image ADHD Therapy

Every parent wants their child to be well-behaved. But when a child has Attention Deficit Hyperactivity Disorder, conventional approaches to teaching good behavior may not work. We look at parenting and teaching strategies that can make a difference...

Treatment Risks in Adult ADHD image Treatment Risks in Adult ADHD

Learn more about treatments for adults with ADHD, and some possible risks associated with these treatments...

View more videos...